Laryngoscope Investigative Otolaryngology,
Journal Year:
2022,
Volume and Issue:
7(2), P. 476 - 485
Published: March 9, 2022
Respiratory,
voice,
and
swallowing
difficulties
after
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
may
result
secondary
to
upper
airway
disease
from
prolonged
intubation
or
mechanisms
related
the
virus
itself.
We
examined
a
cohort
who
presented
with
new
laryngeal
complaints
following
documented
SARS-CoV-2
infection.
characterized
their
airway,
and/or
symptoms
reviewed
clinical
course
of
understand
how
natural
history
these
relates
COVID-19
infections.Retrospective
review
patients
our
department
aerodigestive
as
sequelae
prior
infection
with,
management
of,
SARS-CoV-2.Eighty-one
met
inclusion
criteria.
Median
age
was
54.23
years
(±17.36).
Most
common
presenting
were
dysphonia
(n
=
58,
71.6%),
dysphagia/odynophagia
16,
19.75%),
sore
throat
9,
11.11%).
Thirty-one
(38.27%)
intubation.
Mean
length
16.85
days
(range
1-35).
Eighteen
underwent
tracheostomy
decannulated
an
average
70.69
23-160).
Patients
significantly
more
likely
than
nonintubated
be
diagnosed
granuloma
(8
vs.
0,
respectively,
p
<
.01).
Fifty
(61.73%)
treated
for
without
requiring
muscle
tension
(19
1,
.01)
laryngopharyngeal
reflux
(18
.01).In
persistent
dyspnea,
dysphonia,
dysphagia
recovering
SARS-CoV-2,
early
otolaryngology
consultation
should
considered.
Accurate
diagnosis
prompt
underlying
etiologies
improve
long-term
patient
outcomes.4.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 506 - 506
Published: Jan. 14, 2025
Post/Long
COVID
(syndrome)
is
defined
as
a
condition
with
symptoms
persisting
for
more
than
12
weeks
after
the
onset
of
SARS-CoV-2
infection
that
cannot
be
explained
otherwise.
The
prevalence
self-reported
otorhinolaryngological
high.
aim
this
review
was
to
analyze
current
literature
regarding
actual
prevalence,
knowledge
etiopathology,
and
evidence-based
treatment
recommendations
otorhinolaryngology-related
symptoms.
A
systematic
search
articles
published
since
2019
in
PubMed
ScienceDirect
performed
resulted
108
articles.
These
were
basis
formed
comprehensive
series
consented
therapy
statements
on
most
important
Otorhinolaryngological
did
not
appear
isolated
but
part
multi-organ
syndrome.
Self-reported
often
confirmed
by
objective
testing.
estimated
anosmia,
dysgeusia,
cough,
facial
palsy,
hoarseness/dysphonia,
acute
hearing
loss,
tinnitus,
vertigo/dizziness
about
4%,
2%,
4-19%,
0%,
17-20%,
8%,
20%,
5-26%,
respectively.
There
are
manifold
theoretical
concepts
etiopathology
different
symptoms,
there
no
clear
proof.
This
certainly
contributes
fact
effective
specific
option
any
mentioned.
Healthcare
pathways
must
established
so
can
recognized
evaluated
otorhinolaryngologists
provide
counseling.
would
also
help
establish
selectively
include
patients
clinical
trials
investigating
therapeutic
concepts.
Otolaryngology,
Journal Year:
2023,
Volume and Issue:
168(5), P. 935 - 943
Published: Feb. 26, 2023
Abstract
Objective
To
investigate
the
incidence
rate
of
postextubation
dysphagia
(PED)
in
patients
with
COVID‐19,
as
well
relative
factors
potentially
influencing
clinical
course
dysphagia.
Data
Sources
Six
databases
including
PubMed,
MEDLINE,
Embase,
ScienceDirect,
Cochrane
Central
Register
Controlled
Trials
(CENTRAL),
and
Web
Science
were
searched
no
restriction
on
language.
Review
Methods
The
Preferred
Reporting
Items
for
Systematic
Reviews
Meta‐Analyses
(PRISMA)
guidelines
followed.
extracted
cross‐examined
among
3
authors.
random‐effects
model
was
adopted
statistical
synthesis.
percentage
95%
confidence
interval
(CI)
effect
measurements
PED
rate.
Subgroup
analyses,
sensitivity
metaregression
also
performed
to
identify
heterogeneity
studies.
Results
A
total
594
enrolled
analyzed
from
10
eligible
weighted
COVID‐19
66.5%
(95%
CI:
49.7%‐79.9%).
Age
potential
factor
after
adjusted
by
analysis.
Conclusion
Compared
current
evidence
reporting
only
41%
non‐COVID
experienced
PED,
our
study
further
disclosed
that
a
higher
suffered
which
deserves
global
physicians'
attention.
With
association
between
having
been
more
clearly
understood,
future
clinicians
are
suggested
intubated
patients'
risk
earlier
strengthen
care
programs
era
COVID‐19.
